LH
Lantheus Holdings, Inc. cut its CATX stake below 5%
Lantheus Holdings, Inc. reported owning 3.9% of Perspective Therapeutics, Inc. (CATX) (4,739,011 shares) in a Schedule 13D filed Nov 12, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13D